← Back to Search

Procedure

XPERIENCE Advanced Surgical Irrigation for Osteoarthritis (XPERIENCE Trial)

N/A
Recruiting
Led By Simon Garceau, MD
Research Sponsored by Ottawa Hospital Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 weeks after surgery
Awards & highlights

XPERIENCE Trial Summary

This trial will compare the rate of infection after knee or hip surgery using two different methods of surgical irrigation: XPERIENCE™ Advanced Surgical Irrigation and dilute Betadine.

Who is the study for?
This trial is for adults over 18 with knee or hip arthritis, osteoarthritis, osteonecrosis, or post-traumatic arthritis who need a total knee or hip replacement or hip resurfacing. Participants must be able to follow the study plan and attend all follow-ups.Check my eligibility
What is being tested?
The trial compares XPERIENCE Advanced Surgical Irrigation against dilute Betadine in preventing joint infections after primary total knee arthroplasty (TKA), total hip arthroplasty (THA), or hip resurfacing (HR). It's randomized and controlled to ensure fair results.See study design
What are the potential side effects?
Possible side effects may include skin irritation, allergic reactions, thyroid dysfunction due to iodine absorption from Betadine, and other complications related to surgery such as infection risk.

XPERIENCE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 weeks after surgery, 3 months after surgery, within 90 day of surgery
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 weeks after surgery, 3 months after surgery, within 90 day of surgery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Heart rate
Secondary outcome measures
Patient Reported Functional Outcome Scores
Patient Reported Quality of Life Scores
Rate of PJI at 1 year
+3 more

XPERIENCE Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: XPERIENCE Advanced Surgical IrrigationExperimental Treatment1 Intervention
Patients will receive the XPERIENCE Advanced Surgical Irrigation prior to wound closure.
Group II: Dilute BetadineActive Control1 Intervention
Patients will receive Dilute Betadine solution prior to wound closure.

Find a Location

Who is running the clinical trial?

Ottawa Hospital Research InstituteLead Sponsor
563 Previous Clinical Trials
2,780,114 Total Patients Enrolled
26 Trials studying Osteoarthritis
182,406 Patients Enrolled for Osteoarthritis
Next Science TMIndustry Sponsor
15 Previous Clinical Trials
1,924 Total Patients Enrolled
Simon Garceau, MDPrincipal InvestigatorThe Ottawa Hospital
1 Previous Clinical Trials
80 Total Patients Enrolled
1 Trials studying Osteoarthritis
80 Patients Enrolled for Osteoarthritis

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

In how many medical institutions is this clinical examination currently being conducted?

"Nine patients are currently being enrolled at institutions like McGill University in Ottawa, The Ottawa Hospital in Vancouver, and the University of British Columbia in London, among nine additional sites."

Answered by AI

Are there any available slots for patients to participate in this clinical trial?

"Yes, information from clinicaltrials.gov confirms that recruitment for this research is ongoing. The trial was first listed on April 1st, 2023 and the latest update was made on April 2nd, 2024. Enrollment of approximately 7600 participants will take place across nine designated locations."

Answered by AI

What is the upper limit on the number of individuals enrolled in this clinical trial?

"To conduct the investigation, a total of 7600 eligible individuals meeting the trial's inclusion criteria are required. The sponsor, Next Science TM, will oversee operations at various sites such as McGill University in Ottawa, Ontario and The Ottawa Hospital in Vancouver, British Columbia."

Answered by AI
~5067 spots leftby Mar 2027